U.S. drug shortages highlight dependence on China, gray supply chains – The China Project

Democrats and Republicans both talk about improving America’s ability to make key drugs at home, but the U.S. still relies on China for many medications.

Related Keywords

United States ,Washington ,India ,White House ,District Of Columbia ,China ,University Of Utah ,Utah ,Beijing ,California ,Qilu ,Gansu ,New York ,Manhattan ,America ,Americans ,American ,Chinese ,Charles Tabouchirani ,Erin Fox ,Janet Woodcock ,Us China Business Council ,Biden To Launcha National Biotechnology ,Biomanufacturing Initiative White House ,University Of Utah College Pharmacy ,Us Department Of Commerce ,Discovery Of Cisplatin National Cancer Institute ,Pharmaceuticals Mike Gallagher Website ,House Foreign Affairs Committee ,Atlantic Council ,Pfizer ,Al Jazeera ,Qilu Pharmaceuticals ,China Project ,New York City ,Upper East Side ,Pharmaceutical Supply Chain ,China Act ,Ami Bera ,Utah College ,Biden Administration ,Economic Security Act ,Representatives Mike Gallagher ,Senator Tom Cotton ,Drug Evaluation ,California Democrat ,Platinum Based Treatment ,National Cancer ,President Biden ,National Biotechnology ,Biomanufacturing Initiative ,Colleagues Introduce Bill ,Chinese Manufactured Pharmaceuticals ,Mike Gallagher ,United States Dependent ,China Business ,